Nationality: British and Swiss
Colin Bond has been CFO Sandoz Division since May 1, 2022 and is a member of the Sandoz Executive Committee.
Before joining Sandoz, Colin was CFO at Vifor Pharma from May 2016 to January 2022 and from 2010 to 2016 he was CFO of Evotec AG.
During his early career, Colin worked as auditor and management consultant for Proctor & Gamble, AA and PwC.
Colin is a Fellow of the Institute of Chartered Accountants in England and Wales and Member of the Royal Pharmaceutical Society of Great Britain.
Colin has a BSc. in Pharmacy and an MBA from London Business School.
Colin is a Board Member of BioPharma PLC and previously served as a Board Member of Siegfried Holding AG from 2013 to 2023.